Empowering mental health professionals with peer-reviewed psychiatric research and insights

Page 35

More JCP Articles

JCP
Antipsychotic Efficacy of KarXT (Xanomeline−Trospium)
Original Research

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ May 11, 2022

This post hoc analysis of phase 2 data evaluated rates and time course of response with the new combination oral agent KarXT (xanomeline−trospium) in the treatment of schizophrenia.
JCP
Daily Dose Effects of Risperidone on Metabolic Parameters
JCP
Corrigendum to “Decreases in Suicidality Following Psychedelic Therapy: A Meta-Analysis of Individual Patient Data Across Clinical Trials”
JCP
A Practical Guide for Tailoring Treatment Choices in Interventional Psychiatry
JCP
Epilepsy and Suicide Attempt
JCP
Receipt of Antidepressants and Retention in Buprenorphine Treatment for OUD
JCP
Peer-Delivered Psychotherapy for Postpartum Depression: Reply to Tomfohr-Madsen et al
JCP
Peer-Led Psychotherapy: The Time Is Now
JCP
Economic Burden of PTSD in the US
JCP
Transdiagnostic PRS Prediction of Mood Disorders
JCP
Co-Occurring Depression and Response During OUD Treatment
JCP
Twelve-Month Outcomes for Remitters Following ECT for Depression